ADVANCED HEALTH INTELLIGENCE LTD The Collaboration Agreement between AHI and IntelliGen represents the successful conclusion of an extensive evaluation process by IntelliGen, which encompassed technology functionality, usability, and health evaluation.
The collaboration between AHI and IntelliGen represents a ground-breaking initiative to address the pressing healthcare challenges in the
At the heart of this collaboration is the purpose-focused digital health platform designed to tackle the nation's high rates of chronic disease. The platform's primary goal is to shift the healthcare paradigm from reactive to proactive, focusing on early identification and intervention of chronic diseases rather than episodic care when the problem has already manifested.
It is widely recognised that the region has high rates of chronic diseases. For instance, the
Specifically, the prevalence of diabetes is exceptionally high. According to the
The
The traditional approach to healthcare, which often involves treating patients once symptoms have manifested, is not sufficient to address this escalating issue. We need to shift our focus towards prevention and early intervention, identifying the early markers of chronic diseases and introducing proper care pathways before a health event occurs.
Digitising healthcare is the key to making this shift. By leveraging IntelliGen's and AHI's integration of these cutting-edge technologies, we can collect, analyse, and interpret health data on a scale never before possible. This enables healthcare providers to identify at-risk individuals, monitor disease progression, and intervene at the earliest identifiable juncture. By doing so it will enable the introduction of proper care pathways before a health event happens, ultimately improving patient outcomes and overall healthcare efficiency.
IntelliGen is delivering a purpose-specific digital capability for the Saudi 2030 Health Initiative, which aims to revolutionise healthcare across all sectors. The Health Sector Transformation Program, a key component of this initiative, seeks to establish a comprehensive, effective, and integrated health system that prioritises the health of individuals and society, including citizens, residents, and visitors.
The program is grounded in the principle of value-based care, promoting transparency and financial sustainability. It emphasises public health and disease prevention, striving to improve access to health services through optimal coverage and equitable geographical distribution.
The program also aims to expand the provision of e-health services and digital solutions, enhancing the quality of health services in line with the best evidence-based international standards. It focuses on beneficiary satisfaction, fostering integrated healthcare systems covering all Kingdom regions.
The Health Sector Transformation Program also prioritises societal awareness of traffic and safety, coordinating efforts among all health sector entities, Variable Retention Programs (VRPs), and relevant government entities. This alignment ensures the strategic national goals are met during the transformation journey. IntelliGen is proud to be part of this transformative initiative.
In this context, our collaboration with IntelliGen is of paramount importance. Together, we aim to bring digitised healthcare and early intervention to the
The collaboration between AHI and IntelliGen has the potential to revolutionise healthcare delivery in the Saudi region. By focusing on early identification and intervention of chronic diseases, they aim to foster a healthier future for
The founders of IntelliGen - Zaher,
The success of any initiative is always reliant on the expertise and connections brought by having the right people at the heart of the cause
About
IntelliGen, a pioneering digital healthcare company, is set to revolutionise healthcare delivery in the
IntelliGen aims to address this escalating health crisis by shifting the focus from treatment to prevention and early intervention. Leveraging cutting-edge technologies, data generation, and advanced analytics, our technology identifies early markers of chronic diseases, enabling the introduction of proper care pathways before a health event occurs. This approach will improve patient outcomes and overall healthcare efficiency.
IntelliGen's mission aligns with the ambitious Saudi 2030 Digital Health Initiative, which seeks to integrate digital technologies into every aspect of healthcare delivery. The initiative focuses on enhancing patient experience, improving health outcomes, and reducing costs.
IntelliGen's collaboration with leading technology providers will significantly contribute to this initiative, bringing digitised healthcare and early intervention to the
The founders of IntelliGen, Dr
IntelliGen's target audience includes governments, healthcare providers, and the general population across the
IntelliGen is reshaping the healthcare landscape in the
Contact:
Email: admin@ahi.tech
About
Our mission is to improve healthcare outcomes, enhance health literacy, and support the early detection and management of various health conditions.
Since our inception in 2014, AHI has been at the forefront of Health-tech innovation, starting with the world's first on-device body dimensioning capability. Our patented technology has evolved into a robust suite of solutions symbolising digitised healthcare's future.
Our key offerings include: Body dimension and composition assessments enable the identification of obesity-related comorbidities such as diabetes.
Blood biomarker prediction includes HbA1C, HDL, LDL, and 10-year mortality risk.
Transdermal Optical Imaging, providing vital signs and cardiovascular disease risk estimates.
On-device dermatological skin identification recognises 588 skin conditions across 133 categories, including Melanoma.
Assisting partners in delivering personalised therapeutic and non-therapeutic health coaching to improve daily habits and build health literacy.
At the heart of AHI is our world-class team comprising machine learning and AI experts, computer vision specialists, and medically trained data scientists. Their collective expertise ensures AHI remains at the cutting edge of health-tech innovation, tailoring our technology to meet the evolving needs of our consumers.
AHI's vision extends beyond individual health assessments. We aspire to create a transformative impact at scale, driving forward a new era in digital healthcare. Our biometrically derived triage solution, accessible via a smartphone, enables our partners to identify and manage health risks at a population scale.
In the pursuit of proactive health management, AHI stands ready to guide healthcare providers, caregivers, insurers, and governments in triaging individuals into the most suitable care pathways. Through technology, AHI is contributing to a more efficient, effective, and inclusive global healthcare system.
Cautionary Note Regarding Forward-Looking Statements
This news release contains information or statements that constitute 'forward-looking statements.' Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by words such as 'expects,' 'plans,' 'anticipates,' 'believes,' 'intends,' 'estimates,' 'projects,' 'potential' and similar expressions, or that events or conditions 'will,' 'would,' 'may,' 'could' or 'should' occur.
Forward-looking information may include, without limitation, statements regarding the operations, business, financial condition, expected financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies, and outlook of Advance Health Intelligence, and includes statements about, among other things, future developments and the future operations, strengths, and strategies of Advance Health Intelligence. Forward-looking information is provided for the purpose of presenting information about management's current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. These statements should not be read as guarantees of future performance or results.
The forward-looking statements made, or perceived to be made, in this news release are based on management's assumptions and analysis and other factors that may be drawn upon by management to form conclusions and make forecasts or projections, including management's experience and assessments of historical trends, current conditions and expected future developments. Although management believes that these assumptions, analysis, and assessments are reasonable at the time the statements contained in this news release are made, actual results may differ materially from those projected in any forward-looking statements. Examples of risks and factors that could cause actual results to materially differ from forward-looking statements may include: the timing and unpredictability of regulatory actions; regulatory, legislative, legal or other developments with respect to its operations or business; limited marketing and sales capabilities; early stage of the industry and product development; limited products; reliance on third parties; unfavorable publicity or consumer perception; general economic conditions and financial markets; the impact of increasing competition; the loss of key management personnel; capital requirements and liquidity; access to capital; the timing and amount of capital expenditures; the impact of COVID-19; shifts in the demand for
The forward-looking information contained in this news release represents the expectations of Advance Health Intelligence as of the date of this news release and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. Advance Health Intelligence undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.
(C) 2023 Electronic News Publishing, source
